WO1999050437A1 - Methodology for predicting and/or diagnosing disease - Google Patents
Methodology for predicting and/or diagnosing disease Download PDFInfo
- Publication number
- WO1999050437A1 WO1999050437A1 PCT/US1999/006762 US9906762W WO9950437A1 WO 1999050437 A1 WO1999050437 A1 WO 1999050437A1 US 9906762 W US9906762 W US 9906762W WO 9950437 A1 WO9950437 A1 WO 9950437A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- disease
- samples
- rats
- disorder
- analysis
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/424,805 US6558955B1 (en) | 1998-03-30 | 1999-03-29 | Methodology for predicting and/or diagnosing disease |
JP54960699A JP2002511949A (en) | 1998-03-30 | 1999-03-29 | Method for predicting and / or diagnosing disease |
CA002291889A CA2291889A1 (en) | 1998-03-30 | 1999-03-29 | Methodology for predicting and/or diagnosing disease |
AU33677/99A AU3367799A (en) | 1998-03-30 | 1999-03-29 | Methodology for predicting and/or diagnosing disease |
EP99915073A EP0998579A1 (en) | 1998-03-30 | 1999-03-29 | Methodology for predicting and/or diagnosing disease |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7993598P | 1998-03-30 | 1998-03-30 | |
US60/079,935 | 1998-03-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999050437A1 true WO1999050437A1 (en) | 1999-10-07 |
Family
ID=22153759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/006762 WO1999050437A1 (en) | 1998-03-30 | 1999-03-29 | Methodology for predicting and/or diagnosing disease |
Country Status (6)
Country | Link |
---|---|
US (1) | US6558955B1 (en) |
EP (1) | EP0998579A1 (en) |
JP (1) | JP2002511949A (en) |
AU (1) | AU3367799A (en) |
CA (1) | CA2291889A1 (en) |
WO (1) | WO1999050437A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002057989A2 (en) * | 2001-01-18 | 2002-07-25 | Basf Aktiengesellschaft | Method for metabolic profiling |
EP1285092A4 (en) * | 2000-04-14 | 2003-07-16 | Metabolon Inc | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
JP2004519659A (en) * | 2000-07-18 | 2004-07-02 | コレロジック システムズ,インコーポレイティド | A method for distinguishing between biological states based on patterns hidden from biological data |
JP2005500543A (en) * | 2001-08-13 | 2005-01-06 | ビヨンド ジェノミクス, インコーポレイテッド | Methods and systems for profiling biological systems |
US7329489B2 (en) | 2000-04-14 | 2008-02-12 | Matabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
US8268579B2 (en) | 2008-01-24 | 2012-09-18 | Pilots Point Llc | Method and medium for detecting the presence or absence of pathogenic staphylococci in a first generation test sample |
US8518650B2 (en) | 2006-09-19 | 2013-08-27 | Metabolon, Inc. | Biomarkers for prostate cancer and methods using the same |
CN106153921A (en) * | 2016-08-04 | 2016-11-23 | 北京市神经外科研究所 | Biomarker detectable purposes in the test kit of preparation detection Invasiveness of Pituitary Adenomas |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030232682A1 (en) * | 1998-02-19 | 2003-12-18 | Rogers William D. | Automatic variable ratio differential |
AU8561501A (en) * | 2000-09-22 | 2002-04-02 | Cryosite Ltd | System and method for management of specimens |
US8010295B1 (en) * | 2000-11-06 | 2011-08-30 | IB Security Holders LLC | System and method for selectively classifying a population |
US20070179717A1 (en) * | 2001-09-21 | 2007-08-02 | Milliken Gordon L | System and method for management of specimens |
WO2003046798A1 (en) * | 2001-11-21 | 2003-06-05 | Paradigm Genetics, Inc. | Methods and systems for analyzing complex biological systems |
US20040180003A1 (en) * | 2003-03-12 | 2004-09-16 | Spindler Stephen R. | Methods of screening for caloric restriction mimetics and reproducing effects of caloric restriction |
US20050013776A1 (en) * | 2003-07-16 | 2005-01-20 | Spindler Stephen R. | Methods of evaluating the dynamics of caloric restriction and identifying caloric restriction mimetics |
US7425700B2 (en) * | 2003-05-22 | 2008-09-16 | Stults John T | Systems and methods for discovery and analysis of markers |
US20040236603A1 (en) * | 2003-05-22 | 2004-11-25 | Biospect, Inc. | System of analyzing complex mixtures of biological and other fluids to identify biological state information |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
NZ591879A (en) * | 2003-10-23 | 2012-11-30 | Kineta Two Llc | Detection of mutations in a gene associated with resistance to viral infection, OAS1 |
EP2267154A1 (en) | 2003-10-23 | 2010-12-29 | Illumigen Biosciences, Inc. | Oligoadenylate synthetase |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US20050244973A1 (en) * | 2004-04-29 | 2005-11-03 | Predicant Biosciences, Inc. | Biological patterns for diagnosis and treatment of cancer |
UA95446C2 (en) * | 2005-05-04 | 2011-08-10 | Іллюміджен Байосайєнсіз, Інк. | Mutations in oas1 genes |
EP1999274A2 (en) * | 2006-03-02 | 2008-12-10 | Laboratory Corporation of America Holdings | Methods and systems for evaluating health risk factors by measurement of dna damage and dna repair |
US8849577B2 (en) * | 2006-09-15 | 2014-09-30 | Metabolon, Inc. | Methods of identifying biochemical pathways |
US20080306434A1 (en) | 2007-06-08 | 2008-12-11 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US9452258B2 (en) | 2007-10-09 | 2016-09-27 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US9744155B2 (en) | 2012-03-28 | 2017-08-29 | Ixcela, Inc. | IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk |
EP3786968A1 (en) | 2013-07-19 | 2021-03-03 | Dexcom, Inc. | Time averaged basal rate optimizer |
JP2017516085A (en) | 2014-04-08 | 2017-06-15 | メタボルン インコーポレーティッド | Methods of small-molecule biochemical profiling of individual subjects for disease diagnosis and health assessment |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
CN111246797A (en) | 2017-10-24 | 2020-06-05 | 德克斯康公司 | Pre-attached analyte sensors |
US11041847B1 (en) | 2019-01-25 | 2021-06-22 | Ixcela, Inc. | Detection and modification of gut microbial population |
AU2020326698A1 (en) | 2019-08-05 | 2022-02-24 | Seer, Inc. | Systems and methods for sample preparation, data generation, and protein corona analysis |
CN114354808A (en) * | 2022-01-06 | 2022-04-15 | 南京大学 | Method for high-flux identification of trace organic pollutants in blood based on trace samples |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3855099A (en) | 1971-08-02 | 1974-12-17 | Environmental Sciences Ass Inc | Electrode for anodic stripping voltammetry |
DE2946688A1 (en) | 1978-11-21 | 1980-06-12 | Shandon Southern Prod | METHOD FOR PRODUCING POROESIC CARBON AND POROESIC CARBON |
US4404065A (en) | 1980-01-14 | 1983-09-13 | Enviromental Sciences Associates, Inc. | Electrochemical detection system and method of analysis |
US4863873A (en) * | 1980-01-14 | 1989-09-05 | Esa, Inc. | Method for biological testing and/or developing pharmaceuticals for treatment of disorders |
US4413505A (en) | 1981-03-09 | 1983-11-08 | Environmental Sciences Associates, Inc. | Electrochemical flow cell, particularly use with liquid chromatography |
US4552013A (en) | 1980-01-14 | 1985-11-12 | Esa, Inc. | Electrochemical system |
GB2078128B (en) | 1980-06-24 | 1984-09-12 | Nat Res Dev | Monitoring gases |
US4500432A (en) | 1981-07-13 | 1985-02-19 | Hewlett-Packard Company | Automated sample concentrator for trace components |
DE3686030T2 (en) | 1985-11-13 | 1993-03-04 | Esa Inc | ELECTROCHEMICAL TEST SYSTEM. |
US4976994A (en) | 1985-11-13 | 1990-12-11 | Esa, Inc. | Method for modifying diffusion selectivity of porous fritted carbonaceous electrode |
US5252333A (en) | 1987-04-27 | 1993-10-12 | Scotia Holdings Plc | Lithium salt-containing pharmaceutical compositions |
FR2620620B1 (en) | 1987-09-22 | 1991-04-05 | Atlantic Pharma Prod | INHIBITOR OR DESTRUCTIVE SUBSTANCE OF AT LEAST ONE SINGLE-CELL LIVING BEING CONTAINING FLUORINE F- AND LITHIUM LI + |
US4812344A (en) | 1988-03-28 | 1989-03-14 | Spectran Corporation | Composite capillary tube structure and method of forming |
GB8824780D0 (en) | 1988-10-21 | 1988-11-30 | Unilever Plc | Method of preparation of porous carbon material & material produced by method |
DE3837614A1 (en) | 1988-11-05 | 1990-05-10 | Merck Patent Gmbh | ADSORPTION AGENT FOR CHROMATOGRAPHY |
US5011608A (en) | 1988-11-18 | 1991-04-30 | Dragana Damjanovic | Biogenic amine assay using HPLC-ECD |
US5032240A (en) | 1989-03-27 | 1991-07-16 | Technochem Company | Method of activation of porous carbonaceous electrodes |
US5358802A (en) | 1993-04-01 | 1994-10-25 | Regents Of The University Of California | Doping of carbon foams for use in energy storage devices |
-
1999
- 1999-03-29 WO PCT/US1999/006762 patent/WO1999050437A1/en not_active Application Discontinuation
- 1999-03-29 JP JP54960699A patent/JP2002511949A/en active Pending
- 1999-03-29 AU AU33677/99A patent/AU3367799A/en not_active Abandoned
- 1999-03-29 EP EP99915073A patent/EP0998579A1/en not_active Withdrawn
- 1999-03-29 CA CA002291889A patent/CA2291889A1/en not_active Abandoned
- 1999-03-29 US US09/424,805 patent/US6558955B1/en not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
DATABASE STN MEDLINE 1 January 1900 (1900-01-01), ABAD-ACRUZ A, ET AL: "Liver Function Tests Abnormalities in Patients with Inflammatory Bowel Disease Receiving Artificial Nutrition: A Prospective Randomized Study of Total Enteral Nutrition Versus Total Parenteral Nutrition", XP002921314, Database accession no. 91108912 * |
DATABASE STN MEDLINE 1 January 1900 (1900-01-01), GRANZOTTI, ET AL: "Nutritional Index in Heart Diseases in Childhood", XP002921313, Database accession no. 91248001 * |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7553616B2 (en) | 2000-04-14 | 2009-06-30 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
JP2012185166A (en) * | 2000-04-14 | 2012-09-27 | Metabolon Inc | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
JP2003530130A (en) * | 2000-04-14 | 2003-10-14 | メタボロン インコーポレイテッド | Methods for drug discovery, disease treatment and diagnosis using metabolomics |
US7550258B2 (en) | 2000-04-14 | 2009-06-23 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
US7550260B2 (en) | 2000-04-14 | 2009-06-23 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
EP2330219A3 (en) * | 2000-04-14 | 2011-11-23 | Metabolon, Inc. | Method for drug discovery, disease treatment and diagnosis using metabolomics |
US7005255B2 (en) | 2000-04-14 | 2006-02-28 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
US7329489B2 (en) | 2000-04-14 | 2008-02-12 | Matabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
US20090017464A1 (en) * | 2000-04-14 | 2009-01-15 | Cornell Research Foundation, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
US7947453B2 (en) | 2000-04-14 | 2011-05-24 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
US7910301B2 (en) | 2000-04-14 | 2011-03-22 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
EP1285092A4 (en) * | 2000-04-14 | 2003-07-16 | Metabolon Inc | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
US7682784B2 (en) | 2000-04-14 | 2010-03-23 | Cornell Research Foundation, Inc. | Methods for drug discovery disease treatment, and diagnosis using metabolomics |
US7635556B2 (en) | 2000-04-14 | 2009-12-22 | Cornell Research Foundation, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
US7682783B2 (en) | 2000-04-14 | 2010-03-23 | Cornell Research Foundation, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
JP2004519659A (en) * | 2000-07-18 | 2004-07-02 | コレロジック システムズ,インコーポレイティド | A method for distinguishing between biological states based on patterns hidden from biological data |
WO2002057989A2 (en) * | 2001-01-18 | 2002-07-25 | Basf Aktiengesellschaft | Method for metabolic profiling |
WO2002057989A3 (en) * | 2001-01-18 | 2003-12-31 | Basf Ag | Method for metabolic profiling |
JP2009133867A (en) * | 2001-08-13 | 2009-06-18 | Bg Medicine Inc | Method and system for profiling biological system |
JP2005500543A (en) * | 2001-08-13 | 2005-01-06 | ビヨンド ジェノミクス, インコーポレイテッド | Methods and systems for profiling biological systems |
US8068987B2 (en) | 2001-08-13 | 2011-11-29 | Bg Medicine, Inc. | Method and system for profiling biological systems |
US8518650B2 (en) | 2006-09-19 | 2013-08-27 | Metabolon, Inc. | Biomarkers for prostate cancer and methods using the same |
US8268579B2 (en) | 2008-01-24 | 2012-09-18 | Pilots Point Llc | Method and medium for detecting the presence or absence of pathogenic staphylococci in a first generation test sample |
CN106153921A (en) * | 2016-08-04 | 2016-11-23 | 北京市神经外科研究所 | Biomarker detectable purposes in the test kit of preparation detection Invasiveness of Pituitary Adenomas |
Also Published As
Publication number | Publication date |
---|---|
EP0998579A1 (en) | 2000-05-10 |
US6558955B1 (en) | 2003-05-06 |
CA2291889A1 (en) | 1999-10-07 |
AU3367799A (en) | 1999-10-18 |
JP2002511949A (en) | 2002-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6558955B1 (en) | Methodology for predicting and/or diagnosing disease | |
US10712336B2 (en) | Vitamin D Deficiencies | |
Rafii et al. | High-throughput and simultaneous measurement of homocysteine and cysteine in human plasma and urine by liquid chromatography–electrospray tandem mass spectrometry | |
US10672600B2 (en) | Methods of detecting reverse triiodothyronine by mass spectrometry | |
Kuehnbaum et al. | Multiplexed separations for biomarker discovery in metabolomics: Elucidating adaptive responses to exercise training | |
EP2008108A2 (en) | Means and method for predicting diabetes | |
Carrà et al. | Targeted high resolution LC/MS3 adductomics method for the characterization of endogenous DNA damage | |
WO2018183966A9 (en) | Methods for quantitation of insulin and c-peptide | |
Lorenzini et al. | Assay of endogenous 3, 5-diiodo-L-thyronine (3, 5-T2) and 3, 3′-diiodo-L-thyronine (3, 3′-T2) in human serum: a feasibility study | |
CN113777209A (en) | Synchronous detection and application of exposure and effect markers of volatile pollutants in urine | |
Colletti et al. | Sample multiplexing: increased throughput for quantification of total testosterone in serum by liquid chromatography-tandem mass spectrometry | |
Zelzer et al. | Comparison of two LC-MS/MS methods for the quantification of 24, 25-dihydroxyvitamin D3 in patients and external quality assurance samples | |
Neumann et al. | Sensitive determination of ethyl glucuronide in serum and whole blood: detection time after alcohol exposure compared with urine | |
JP5068819B2 (en) | Means and methods for examining hemolytic anemia | |
US20050176089A1 (en) | Methods and devices for retrieving a subject's physiological history from a biological sample analysis | |
Inoue et al. | Rapid and sensitive method for prenatal diagnosis of propionic acidemia using stable isotope dilution gas chromatography–mass spectrometry and urease pretreatment | |
Furlani et al. | Liquid chromatography-mass spectrometry for clinical metabolomics: an overview | |
O'Maille et al. | Metabolomics relative quantitation with mass spectrometry using chemical derivatization and isotope labeling | |
Evans et al. | Analysis of urinary 8-oxo-7, 8-dihydro-2′-deoxyguanosine by liquid chromatography–tandem mass spectrometry | |
Stobaugh | Strategies for Differential Proteomic Analysis by Liquid Chromatography-Mass Spectrometry | |
Siddiqi | Development of a Targeted MS-based Method for Measurement of Insulin, Cortisol, Glucagon-like peptide 1, acyl and desacyl Ghrelin, and Carboxylated Osteocalcin in Porcine Serum | |
Chakraborty et al. | Mass Spectrometry-Based Profiling of Metabolites in Human Biofluids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999915073 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2291889 Country of ref document: CA Ref country code: CA Ref document number: 2291889 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1999 549606 Kind code of ref document: A Format of ref document f/p: F |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09424805 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999915073 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999915073 Country of ref document: EP |